KUALA LUMPUR (June 11): PublicInvest Research has initiated coverage on Optimax Holdings Bhd (KL:OPTIMAX) with an “outperform” rating at 68 sen and a target price (TP) of 83 sen, based on a 27x price earnings ratio pegged to FY2025F earnings per share of 3.1 sen.

In a note on Tuesday, the research house said it believes Optimax’s growth prospect hinges on growing demand for cataract surgeries, fuelled by an increasing ageing population in Malaysia, whereby the proportion of individuals aged 65 and above has increased from 7.2% in 2022 to 7.4% in 2023, totalling approximately 2.5 million people.

Furthermore, PublicInvest said a surge in diagnosed diabetes cases and the increased usage of electronic gadgets may lead to higher occurrence of eye-related diseases.

At the time of writing, Optimax added 0.74% or 0.5 sen to 68.5 sen, with 154,800 shares traded.